Loading insider details...
Beta
Latest Form 4 (Sep 3, 2026): Disposition to Issuer of 920,941 APGE shares.
Every alert includes an AI-written analysis of the filing, plus news and market context.
| Filed | Company | Transaction | Shares | Value |
|---|---|---|---|---|
| Sep 3, 2026 | Apogee Therapeutics, Inc. (APGE) | Disposition to Issuer | 920,941 | n/a |
| Jul 11, 2026 | Apogee Therapeutics, Inc. (APGE) | Sale | 20,000 | $2.67M |
| Jun 25, 2026 | Apogee Therapeutics, Inc. (APGE) | Sale | 80,000 | $10.60M |
| Jun 24, 2026 | Spyre Therapeutics, Inc. (SYRE) | Sale | 20,000 | $2.00M |
| Jun 12, 2026 | Apogee Therapeutics, Inc. (APGE) | Sale | 6,770 | $556.6K |
| May 29, 2026 | Spyre Therapeutics, Inc. (SYRE) | Grant/Award | 8,026 | n/a |
| May 16, 2026 | Apogee Therapeutics, Inc. (APGE) | Sale | 18,659 | $1.53M |
| May 9, 2026 | Spyre Therapeutics, Inc. (SYRE) | Sale | 2,404 | $174.5K |
| Apr 20, 2026 | Apogee Therapeutics, Inc. (APGE) | Exercise/Conversion | 3,000 | $68.6K |
| Apr 11, 2026 | Apogee Therapeutics, Inc. (APGE) | Sale | 17,800 | $1.47M |